Global Pharmacovigilance Outsourcing Market Size, Share and Forecast 2032

Pharmacovigilance Outsourcing Industry Perspective

What will be the global pharmacovigilance outsourcing market size during the forecast period?

The global pharmacovigilance outsourcing market size was worth around USD 3.76 billion in 2023 and is predicted to reach around USD 13.05 billion by 2032, with a compound annual growth rate (CAGR) of roughly 14.84% between 2024 and 2032.

This report provides a comprehensive analysis of the growth drivers, restraints, and challenges shaping demand across the global pharmacovigilance outsourcing market throughout the forecast period, while highlighting high-potential emerging opportunities within the industry.

Request Free Sample

Key Insights

• According to our research analyst, the global pharmacovigilance outsourcing market is estimated to grow at a CAGR of around 14.84% over the forecast period (2024-2032).
• In terms of revenue, the global pharmacovigilance outsourcing market size was valued at around USD 3.76 billion in 2023 and is projected to reach USD 13.05 billion by 2032.
• The pharmacovigilance outsourcing market is driven by rising maintenance costs of in-house pharmacovigilance infrastructure, shortage of expert staff, and the need for specialized compliance expertise and scalability.
• By service provider segment, contract research organizations lead, leveraging specialized expertise, established processes, and the ability to deliver cost-effective, scalable solutions.
• By service segment, post-marketing services hold a prominent position because of ongoing requirements for adverse event monitoring, risk management, and regulatory reporting after product launch.
• North America is expected to contribute significantly to the global market, supported by the strong presence of large biopharmaceutical and pharmaceutical companies and the high volume of drug discoveries and approvals.

Pharmacovigilance Outsourcing Market: Overview

Pharmacovigilance outsourcing is the transfer of drug safety operations and processes to a third-party service provider by the life science firm.  Primary pharmacovigilance outsourcing activities include case processing and compliance management. In addition, Pharmacovigilance outsourcing also includes core and management activities.

Core pharmacovigilance outsourcing activities include gathering data associated with adverse drug reactions (ADRs), preparing risk management strategies and risk assessment mitigation strategies, and creating and submitting expedited & aggregate pharmacovigilance reports.

Furthermore, management pharmacovigilance outsourcing activities include preparing standard operating procedures and other controlled quality documents. This also includes supporting internal & external compliance reporting; testing and checking business processes & systems for compliance; carrying out trend analyses & predictive modeling for compliance functions; and developing comprehensive descriptions of the pharmacovigilance system.

In addition, management pharmacovigilance outsourcing activities include drafting or revising safety data exchange contracts with third parties or business partners, inspecting readiness training, checking pharmacovigilance system updates, and developing  & implementing corrective & preventive action policies.

Pharmacovigilance Outsourcing Market: Growth Drivers

What factors are primarily accelerating demand in the pharmacovigilance outsourcing market?

Demand for strong compliance systems and pharmacovigilance expertise, and the need for talented professionals to maintain pharmacovigilance infrastructure, have increased the maintenance cost of pharmacovigilance infrastructure. This is likely to boost demand for outsourcing pharmacovigilance activities to minimize the firm's maintenance costs.

Moreover, even with large-scale funding for pharmacovigilance operations, a firm may still struggle to improve the quality of its pharmacovigilance activities and compliance due to a lack of expert staff to perform in-house pharmacovigilance functions. This, in turn, will drive growth in the pharmacovigilance outsourcing market in the years ahead.

Additionally, service providers are focusing on developing & maintaining up-to-date knowledge of pharmacovigilance activities by hiring experienced pharmacovigilance experts. These moves also help them manage costs. They also bring process agendas, execute industry-tested procedures rigorously, build deep knowledge & expertise by delivering similar services for other clients, and provide just-in-time delivery of value-based pharmacovigilance outsourcing solutions. This allows organizations to focus on core strategic goals and reduces the costs associated with deploying and maintaining pharmacovigilance systems. These factors will expand business scope in the coming years.

Pharmacovigilance outsourcing providers can help firms address the growing size and complexity of regulations, improve scalability to support expanding product portfolios, and achieve economies of scale while meeting cost targets. Pharmacovigilance outsourcing can free management to focus on core capabilities and business performance. These factors will drive market growth trends in the forecast years.

Pharmacovigilance Outsourcing Market: Restraints

What factors are limiting the expansion of the pharmacovigilance outsourcing market?

Data quality concerns, the complexity of navigating multi-regional regulatory requirements, and confidentiality or data security risks can restrain broader adoption. Organizations must carefully evaluate provider capabilities to ensure seamless integration and reliable outcomes.

Variations in pharmacovigilance system maturity across companies, along with the need for clear governance frameworks, can also slow decision-making on outsourcing initiatives.

Pharmacovigilance Outsourcing Market: Opportunities

Where do significant growth opportunities lie for the pharmacovigilance outsourcing market?

Increasing volumes of clinical trials, growing post-market surveillance requirements, and the continuous introduction of new therapies create expanding demand for specialized safety services. Cost optimization pressures and the need for global regulatory compliance further encourage life science companies to outsource.

Providers that combine deep domain expertise with technology-enabled solutions, including advanced analytics and automation, are well positioned to capture opportunities arising from portfolio expansion and evolving safety obligations.

Pharmacovigilance Outsourcing Market: Challenges

What key challenges do participants in the pharmacovigilance outsourcing market face?

Ensuring consistent data quality, maintaining strict confidentiality, and managing the intricacies of diverse regulatory landscapes remain ongoing challenges. Providers must continuously invest in talent, technology, and process excellence to meet client expectations.

Aligning outsourced activities with a company’s internal systems, culture, and governance requirements demands careful partnership management and transparent communication.

Request Free Sample

Pharmacovigilance Outsourcing Market: Report Scope

Pharmacovigilance Outsourcing Market: Segmentation

The pharmacovigilance outsourcing market is segmented by service provider, service, and region. All the segments of the pharmacovigilance outsourcing market have been analyzed based on present and future trends, and the market is estimated from 2024 to 2032.

Based on Service Provider Segment, the pharmacovigilance outsourcing market is divided into business processing outsourcing and contract research organizations. Contract research organizations dominate because they combine specialized pharmacovigilance expertise with scalable delivery models and proven processes refined across multiple clients. Their ability to supply experienced professionals, maintain up-to-date regulatory knowledge, and deliver cost-effective solutions helps life science companies reduce infrastructure burdens and improve compliance quality, thereby driving overall market expansion. Both categories support growth by enabling clients to focus on core research and commercial activities while ensuring robust safety operations.

Based on Service Segment, the pharmacovigilance outsourcing market is divided into post-marketing services (IT solutions and services, knowledge process outsourcing services) and pre-marketing services (case-processing services, clinical pharmacovigilance services, medical review, and safety data management services). Post-marketing services hold a leading position because of the ongoing need for adverse event collection, risk management, aggregate reporting, and long-term safety monitoring after products reach the market. This ongoing requirement generates sustained demand and supports market stability. Pre-marketing services, including case processing, clinical pharmacovigilance, medical review, and safety data management, form the second major area and contribute to growth by addressing safety needs during clinical development and regulatory submission phases, enabling earlier risk identification and compliance readiness.

Pharmacovigilance Outsourcing Market: Regional Analysis

Why will North America continue to dominate the global market during the projection period?

North America is expected to contribute significantly to the global pharmacovigilance outsourcing market. The region benefits from the concentration of large biopharmaceutical and pharmaceutical companies, particularly in the United States, which generate substantial demand for specialized safety services. A high volume of drug discoveries and regulatory approvals by the U.S. FDA further increases the need for robust pharmacovigilance support across both clinical and post-marketing stages. Established outsourcing ecosystems, advanced regulatory frameworks, and the presence of leading service providers reinforce regional leadership. This dominance drives overall market growth by setting high standards for quality and compliance, encouraging continuous innovation in service delivery models, and supporting the global expansion of outsourced pharmacovigilance capabilities.

Europe maintains a strong position supported by rigorous regulatory requirements and a mature pharmaceutical industry. Asia Pacific is advancing as clinical trial activity expands and local life science companies increasingly adopt outsourcing to meet international standards. Latin America and the Middle East and Africa are progressing gradually as regulatory systems develop and awareness of structured pharmacovigilance practices grows.

Pharmacovigilance Outsourcing Market: Competitive Landscape

The global pharmacovigilance outsourcing market profiles key players such as:

• Genpact
• Bioclinica
• Tata Consultancy Services (TCS)
• Accenture
• PRA Health Sciences
• Clintec
• SIRO Clinpharm
• CliniRx Tangent Research
• Covance
• Infosys
• Tech Mahindra
• Cognizant
• Ergomed
• IBM
• HCL Technologies
• iGATE
• ICON
• iMED Global
• Medpace Holdings
• IQVIA
• Oracle
• Novartis
• Parexel
• Symogen
• Syneos Health.

Pharmacovigilance Outsourcing Market: Key Trends

What are the key trends in the pharmacovigilance outsourcing market?

Growing reliance on specialized expertise and cost-efficient models

Life science companies are increasingly outsourcing to access experienced professionals, standardized processes, and economies of scale. This trend allows internal teams to concentrate on core strategic priorities while ensuring high-quality compliance and risk management.

Adoption of technology-enabled and AI-supported solutions

Providers are incorporating advanced analytics, automation, and artificial intelligence for adverse event detection, case processing, and signal management. These innovations improve efficiency, scalability, and the ability to handle rising data volumes across global operations.

Segments Covered

The global pharmacovigilance outsourcing market is segmented as follows:

By Service Provider

• Business Processing Outsourcing
• Contract Research Organizations

By Service

• Post-marketing Services
  • IT Solutions & Services
  • Knowledge Process Outsourcing Services
• Pre-marketing Services
  • Case-Processing Services
  • Clinical Pharmacovigilance Services
  • Medical Review
  • Safety Data Management Services

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America